ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the target of a large decrease in short interest in the month of May. As of May 31st, there was short interest totalling 11,300 shares, a decrease of 15.7% from the May 15th total of 13,400 shares. Based on an average trading volume of 8,700 shares, […]
Shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) fell 0.9% on Monday . The company traded as low as $19.84 and last traded at $19.89. 7,269 shares changed hands during trading, a decline of 44% from the average session volume of 12,996 shares. The stock had previously closed at $20.07. ProShares UltraShort Nasdaq […]
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totalling 13,600 shares, a decrease of 20.0% from the April 15th total of 17,000 shares. Based on an average daily volume of 12,600 shares, the days-to-cover ratio […]
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the recipient of a significant decrease in short interest in April. As of April 30th, there was short interest totalling 13,600 shares, a decrease of 20.0% from the April 15th total of 17,000 shares. Based on an average daily trading volume, of 12,600 shares, the short-interest […]
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the recipient of a large drop in short interest in March. As of March 31st, there was short interest totalling 18,800 shares, a drop of 42.5% from the March 15th total of 32,700 shares. Based on an average trading volume of 15,700 shares, the short-interest ratio […]